| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Ensysce Biosciences, Inc.
13D/A
ENSC · 293602504
|
6.1% |
8/18/2026
Event 8/7/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.